DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Pharmacokinetics of Pavaverine After Intraluminal Administration

Information source: Johann Wolfgang Goethe University Hospitals
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Injury of Internal Mammary Artery; Complications Due to Coronary Artery Bypass Graft

Intervention: CABG (Procedure)

Phase: N/A

Status: Completed

Sponsored by: Johann Wolfgang Goethe University Hospitals

Official(s) and/or principal investigator(s):
Arndt H Kiessling, MD, Principal Investigator, Affiliation: Johann Wolfgang Goethe University Hospitals

Summary

The purpose of this study is to determine the pharmacokinetic of papaverine after administration into the artery mammaria interna.

Clinical Details

Official title: Observational Study on Papaverine During Cardiac Surgical Procedures

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: Maximum plasma concentration of papaverine

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- CABG

- Administration of papaverine into mammaria interna

Exclusion Criteria:

- Allergy against papaverine

Locations and Contacts

Klinikum der Goethe Universit├Ąt Frankfurt, Frankfurt am Main, Hessen 60590, Germany
Additional Information

Starting date: October 2012
Last updated: June 3, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017